Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 7 publications
MK-7602: a potent multi-stage dual-targeting antimalarial.
Journal: EBioMedicine
Published: June 23, 2025
Pharmacologic characterization of atogepant: A potent and selective calcitonin gene-related peptide receptor antagonist.
Journal: Cephalalgia : an international journal of headache
Published: January 12, 2024
Evaluation of luciferase and prefusion-stabilized F protein from respiratory syncytial virus mRNA/LNPs in pre-clinical models using jet delivery compared to needle and syringe.
Journal: Vaccine: X
Published: August 03, 2023
Transforaminal lumbar puncture for intrathecal access: Case series with literature review and comparison to other techniques.
Journal: Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia
Published: September 25, 2019
Characterization of Ubrogepant: A Potent and Selective Antagonist of the Human Calcitonin Gene‒Related Peptide Receptor.
Journal: The Journal of pharmacology and experimental therapeutics
Published: August 12, 2019
Nav1.7 target modulation and efficacy can be measured in nonhuman primate assays.
Journal: Science translational medicine
Published: May 29, 2019
Novel oxazolidinone calcitonin gene-related peptide (CGRP) receptor antagonists for the acute treatment of migraine.
Journal: Bioorganic & medicinal chemistry letters
Published: June 16, 2015
Showing 1-7 of 7
Last Updated: 09/26/2026